Joseph Michael Fitzgerald is EVP & Group Pres, Cardiology of BOSTON SCIENTIFIC CORP. Currently has a direct ownership of 148,118 shares of BSX, which is worth approximately $13.2 Million. The most recent transaction as insider was on Feb 15, 2022, when has been sold 2,278 shares (Common Stock) at a price of $44.01 per share, resulting in proceeds of $100,255. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 148K
16.01% 3M change
25.19% 12M change
Total Value Held $13.2 Million

Joseph Michael Fitzgerald Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 15 2022
SELL
Payment of exercise price or tax liability
$100,255 $44.01 p/Share
2,278 Reduced 1.07%
210,088 Common Stock
Feb 15 2022
BUY
Exercise of conversion of derivative security
-
4,614 Added 2.13%
212,366 Common Stock
Feb 07 2022
SELL
Bona fide gift
-
2,780 Reduced 1.32%
207,752 Common Stock
Jan 01 2022
SELL
Payment of exercise price or tax liability
$301,566 $42.48 p/Share
7,099 Reduced 3.26%
210,532 Common Stock
Jan 01 2022
BUY
Exercise of conversion of derivative security
-
14,035 Added 6.06%
217,631 Common Stock
Jul 27 2021
SELL
Open market or private sale
$4,747,050 $45.0 p/Share
105,490 Reduced 34.13%
203,596 Common Stock
Jul 27 2021
BUY
Exercise of conversion of derivative security
$441,522 $6.28 p/Share
70,306 Added 18.53%
309,086 Common Stock
May 06 2021
SELL
Bona fide gift
-
12,000 Reduced 4.79%
238,780 Common Stock
Mar 03 2021
SELL
Payment of exercise price or tax liability
$69,061 $38.82 p/Share
1,779 Reduced 0.7%
250,780 Common Stock
Mar 03 2021
BUY
Exercise of conversion of derivative security
-
3,603 Added 1.41%
252,559 Common Stock
Feb 22 2021
SELL
Payment of exercise price or tax liability
$78,478 $39.2 p/Share
2,002 Reduced 0.8%
248,956 Common Stock
Feb 22 2021
BUY
Exercise of conversion of derivative security
-
4,056 Added 1.59%
250,958 Common Stock
Feb 21 2021
SELL
Payment of exercise price or tax liability
$73,094 $38.03 p/Share
1,922 Reduced 0.77%
246,902 Common Stock
Feb 21 2021
BUY
Exercise of conversion of derivative security
-
3,894 Added 1.54%
248,824 Common Stock
Feb 18 2021
SELL
Payment of exercise price or tax liability
$68,624 $37.52 p/Share
1,829 Reduced 0.74%
244,930 Common Stock
Feb 18 2021
BUY
Exercise of conversion of derivative security
-
3,706 Added 1.48%
246,759 Common Stock
Feb 15 2021
SELL
Payment of exercise price or tax liability
$87,452 $38.39 p/Share
2,278 Reduced 0.93%
243,053 Common Stock
Feb 15 2021
BUY
Exercise of conversion of derivative security
-
4,614 Added 1.85%
245,331 Common Stock
Feb 10 2021
SELL
Payment of exercise price or tax liability
$345,027 $38.85 p/Share
8,881 Reduced 3.56%
240,717 Common Stock
Feb 10 2021
BUY
Grant, award, or other acquisition
-
17,995 Added 6.72%
249,598 Common Stock
Feb 08 2021
SELL
Bona fide gift
-
3,040 Reduced 1.3%
231,603 Common Stock
Jan 01 2021
SELL
Payment of exercise price or tax liability
$489,603 $35.95 p/Share
13,619 Reduced 5.49%
234,628 Common Stock
Jan 01 2021
BUY
Exercise of conversion of derivative security
-
27,199 Added 9.87%
248,247 Common Stock
JMF

Joseph Michael Fitzgerald

EVP & Group Pres, Cardiology
Marlborough, MA

Track Institutional and Insider Activities on BSX

Follow BOSTON SCIENTIFIC CORP and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BSX shares.

Notify only if

Insider Trading

Get notified when an Boston Scientific Corp insider buys or sells BSX shares.

Notify only if

News

Receive news related to BOSTON SCIENTIFIC CORP

Track Activities on BSX